These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20200462)

  • 1. [Antiplatelet treatment after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura].
    Can MM; Tanboğa IH; Boztosun B; Kaymaz C
    Turk Kardiyol Dern Ars; 2009 Dec; 37(8):575-7. PubMed ID: 20200462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review.
    Li-Sha G; Peng C; Yue-Chun L
    BMC Cardiovasc Disord; 2015 Sep; 15():101. PubMed ID: 26385102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo?
    Moretti C; Teresa Lucciola M; Morena L; Biondi-Zoccai G; Laudito A; Anselmino M; Paolo Trevi G; Sheiban I
    Int J Cardiol; 2008 Nov; 130(3):e96-7. PubMed ID: 17854925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.
    Stouffer GA; Hirmerova J; Moll S; Rubery B; Napoli M; Ohman EM; Simpson R
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):364-7. PubMed ID: 14988897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura.
    Fuchi T; Kondo T; Sase K; Takahashi M
    Jpn Circ J; 1999 Feb; 63(2):133-6. PubMed ID: 10084377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance.
    Mendolicchio GL; Zavalloni D; Bacci M; Roveda M; Quagliuolo V; Anselmi CV; Rota LL; Ruggeri ZM
    Thromb Haemost; 2015 Mar; 113(3):664-7. PubMed ID: 25428265
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention.
    Russo A; Cannizzo M; Ghetti G; Barbaresi E; Filippini E; Specchia S; Branzi A
    Interact Cardiovasc Thorac Surg; 2011 Aug; 13(2):153-7. PubMed ID: 21576275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary revascularization in a patient with immune thrombocytopenic purpura.
    Fong MC; Chen KC; Leu HB; Chen LC
    J Chin Med Assoc; 2006 Sep; 69(9):436-8. PubMed ID: 17051755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of intracoronary stent implanted for acute myocardial infarction in an elderly patient with idiopathic thrombocytopenic purpura].
    Kikuchi S; Hayashi Y; Fujioka S; Kukita H; Ochi N
    Nihon Ronen Igakkai Zasshi; 2002 Jan; 39(1):88-93. PubMed ID: 11857981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary artery compression by a localized epicardial hematoma in a patient with idiopathic thrombocytopenic purpura after percutaneous coronary intervention: a case report.
    Kawaguchi S; Takeuchi T; Hasebe N
    BMC Cardiovasc Disord; 2016 Oct; 16(1):206. PubMed ID: 27793101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.
    Gajos G; Rostoff P; Undas A; Piwowarska W
    J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary percutaneous coronary intervention for acute myocardial infarction with idiopathic thrombocytopenic purpura: a case report.
    Kim JH; Park KU; Chun WJ; Kim SH; Nah DY
    J Korean Med Sci; 2006 Apr; 21(2):355-7. PubMed ID: 16614529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura associated with clopidogrel administration: case report and brief review.
    Nara W; Ashley I; Rosner F
    Am J Med Sci; 2001 Sep; 322(3):170-2. PubMed ID: 11570785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.
    Neskovic AN; Stankovic I; Milicevic P; Aleksic A; Vlahovic-Stipac A; Calija B; Putnikovic B
    Herz; 2010 Jan; 35(1):43-9. PubMed ID: 20140789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Trenk D; Hochholzer W; Fromm MF; Chialda LE; Pahl A; Valina CM; Stratz C; Schmiebusch P; Bestehorn HP; Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2008 May; 51(20):1925-34. PubMed ID: 18482659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Minimally invasive direct coronary artery bypass in a patient with idiopathic thrombocytopenic purpura; report of a reoperative case].
    Gotoh H; Fukaya Y; Kohno T; Amano J
    Kyobu Geka; 2002 Nov; 55(12):1049-52. PubMed ID: 12428340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
    Mehilli J; Kastrati A; Schühlen H; Dibra A; Dotzer F; von Beckerath N; Bollwein H; Pache J; Dirschinger J; Berger PP; Schömig A;
    Circulation; 2004 Dec; 110(24):3627-35. PubMed ID: 15531766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.